NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/14/2026
Back to search
Official data from USPTO
BUSCOPAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
05/15/2026
Trademark type
Combined
Nice classes
5
Filing date
06/12/2018
Registration date
09/10/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/27/2026
Last transaction
05/15/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
DE
Examiner
MICKLEBURGH, LINDA BOHANNON
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
A. NATTERMANN & Cie GMBH
Sanofi-Aventis Deutschland GmbH
Representatives
Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinesantispasmodicsanticholinergicsanalgesicsantacidsantiflatulentsantiulcerants
Publications
History of USPTO decisions and trademark events.
40 publications found
C71T
CANCELLED SECTION 71
03/27/2026
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/03/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/14/2023
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
02/07/2020
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/24/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/09/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/09/2020
FIMP
FINAL DISPOSITION PROCESSED
01/09/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
01/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
09/10/2019
GPNX
NOTIFICATION PROCESSED BY IB
07/12/2019
PUBO
PUBLISHED FOR OPPOSITION
06/25/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/05/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/05/2019
NPUB
NOTICE OF PUBLICATION
06/05/2019
ALIE
ASSIGNED TO LIE
05/17/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/18/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/17/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/17/2019
CNRT
NON-FINAL ACTION MAILED
01/18/2019
CNRT
NON-FINAL ACTION WRITTEN
01/17/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/15/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/15/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/11/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/11/2019
RFNT
REFUSAL PROCESSED BY IB
08/31/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/08/2018
RFRR
REFUSAL PROCESSED BY MPU
08/08/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/27/2018
CNRT
NON-FINAL ACTION WRITTEN
07/26/2018
DOCK
ASSIGNED TO EXAMINER
07/24/2018
MAFR
APPLICATION FILING RECEIPT MAILED
07/24/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/18/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/16/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/12/2018
Continuous trademark protection
Get notified about every new filing that threatens BUSCOPAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.